{"result": {"id": "32578daf-1d3d-4966-9278-d033c7bc97e6", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>BLOOD PRESSURE<|>EVENT<|>A key vital sign monitored in hypertension management, with specific targets for control\")\n##\n(\"entity\"<|>BMI<|>EVENT<|>Body Mass Index, an important metric tracked in hypertension follow-ups to assess obesity risk\")\n##\n(\"entity\"<|>HEART RATE<|>EVENT<|>A cardiovascular parameter monitored during hypertension management\")\n##\n(\"entity\"<|>BLOOD TESTS<|>EVENT<|>Laboratory tests including blood potassium, glucose, and lipid profile used to monitor hypertension complications\")\n##\n(\"entity\"<|>URINE TESTS<|>EVENT<|>Urinalysis performed to assess kidney function in hypertensive patients\")\n##\n(\"entity\"<|>ECG<|>EVENT<|>Electrocardiogram used to evaluate cardiac status in hypertension patients\")\n##\n(\"entity\"<|>ULTRASOUND<|>EVENT<|>Imaging tests like echocardiogram and carotid ultrasound used to assess organ damage in hypertension\")\n##\n(\"relationship\"<|>BLOOD PRESSURE<|>HYPERTENSION<|>Blood pressure measurement is the primary diagnostic and monitoring tool for hypertension<|>9)\n##\n(\"relationship\"<|>BMI<|>HYPERTENSION<|>High BMI is both a risk factor and monitoring parameter for hypertension<|>7)\n##\n(\"relationship\"<|>HEART RATE<|>CARDIOVASCULAR DISEASE<|>Abnormal heart rate may indicate cardiovascular complications from hypertension<|>6)\n##\n(\"relationship\"<|>BLOOD TESTS<|>HYPERTENSION<|>Blood tests help monitor metabolic complications of hypertension<|>7)\n##\n(\"relationship\"<|>URINE TESTS<|>HYPERTENSION<|>Urine tests assess kidney damage from long-term hypertension<|>7)\n##\n(\"relationship\"<|>ECG<|>CARDIOVASCULAR DISEASE<|>ECG detects cardiac abnormalities caused by hypertensive heart disease<|>8)\n##\n(\"relationship\"<|>ULTRASOUND<|>CARDIOVASCULAR DISEASE<|>Ultrasound imaging evaluates end-organ damage from hypertension<|>7)\n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1752165543, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 505, "prompt_tokens": 2813, "total_tokens": 3318, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2752}, "prompt_cache_hit_tokens": 2752, "prompt_cache_miss_tokens": 61}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: <16次/min、\n硫酸镁“\t释至20ml,每4小时一次深部肌肉注射，总量25~30 g/d(妊 娠高血压、严重先兆子痫)\t-\t\t腱反射消失时应及时停药\n注：“非高血压药物；急症降压药使用详见各种药物的说明书；-无\n\n\n治疗等。\n　　　2.客观资料采集(O):  包括体格检查，常规实验 室检查及辅助检查等。\n　　　3. 健康问题评估(A):  患者存在的健康问题及 危险因素；疾病控制情况；有无相关并发症；并发症 是否改善等。\n　　　4.制定随访计划(P):  包括危险因素干预计划、 治疗计划、检查计划、随访计划等。\n(二)随访评估\n　　　目的是评估心血管病发病风险、靶器官损害及  并存的临床情况，是确定高血压治疗策略的基础。 评估内容见表6。\n(三)随访频次\n\n\n　　　1.对血压控制满意，无药物不良反应，无新发 并发症或原有并发症无加重者，预约下一次随访时 间，每1~3个月随访一次。\n　　　2.第一次出现血压控制不满意或出现药物不 良反应的患者，结合服药依从性，必要时增加现用 药物剂量，更换或增加不同类降压药物，2周内 随 访 。\n　　　3.对连续2次出现血压控制不满意或药物不 良反应难以控制，以及出现新并发症或原有并发症 加重的患者，建议转诊上级医院，2周内主动随访 转诊情况。\n(四)健康教育\n对所有患者及家属进行有针对性的健康教育，\n\n\n\n表6高  血压随访评   估内容\n\n监测项目\t初诊\t每次随访\t季度随访\t年度随访\n症状\t√\t√\t√\t√\n血压\t√\t√\t√\t√\n体重\t√\t\t√\t√\nBMI\t√\t\t\t√\n心率\t√\t√\t\t√\n饮食指导\t√\t√\t√\t√\n运动指导\t√\t√\t√\t√\n心理咨询\t√\t√\t√\t√\n服药依从性\tV\t√\t√\t√\n药物不良反应\t√\t√\t√\t√\n血常规\t√\t\t\t√\n尿常规\t√\t\t\t√\n血钾\t√\t\t\t√\n血糖\t√\t\t\t√\n血脂四项\t√\t\t\t√\n肌酐、尿素氮\t√\t\t\t√\n肝功能\t√\t\t\t√\n心电图\t√\t\t\t√\n动态血压\t选做\t\t\t选做\n超声心动图\t选做\t\t\t选做\n颈动脉B型超声\t选做\t\t\t选做\n尿白蛋白/肌酐\t选做\t\t\t选做\n胸片\t选做\t\t\t选做\n眼底检查\t选做\t\t\t选做\n并贯穿管理始终，内容包括对疾病的认识，饮食、运 动指导，心理支持，血压自我监测等，与患者 一 起制 定生活方式改进目标，并在下一次随�\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>SULFATE MAGNESIUM<|>ORGANIZATION<|>A medication used for treating severe preeclampsia and pregnancy-induced hypertension, administered via deep intramuscular injection every 4 hours with a total daily dose of 25~30 g/d\")\n##\n(\"entity\"<|>HYPERTENSION<|>EVENT<|>A medical condition characterized by high blood pressure, requiring regular follow-ups and management to prevent complications\")\n##\n(\"entity\"<|>FOLLOW-UP PLAN<|>EVENT<|>A structured plan for monitoring and managing hypertension, including risk factor intervention, treatment adjustments, and regular check-ups\")\n##\n(\"entity\"<|>CARDIOVASCULAR DISEASE<|>EVENT<|>A health condition related to the heart and blood vessels, often associated with hypertension and requiring risk assessment and management\")\n##\n(\"relationship\"<|>SULFATE MAGNESIUM<|>HYPERTENSION<|>Sulfate Magnesium is used to treat severe cases of hypertension such as preeclampsia<|>7)\n##\n(\"relationship\"<|>HYPERTENSION<|>FOLLOW-UP PLAN<|>Hypertension management requires a detailed follow-up plan to monitor and adjust treatment<|>8)\n##\n(\"relationship\"<|>HYPERTENSION<|>CARDIOVASCULAR DISEASE<|>Hypertension is a major risk factor for cardiovascular diseases<|>9)\n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": null, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_e22699ccd1f38577d1aa878502c05daa0082676765daa5bd6387069d4d56e447_v2"}